Board Change • Dec 30
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Gustavo Gonzalez was the last independent director to join the board, commencing their role in 2024. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Reported Earnings • Sep 01
Third quarter 2024 earnings released: CA$0.006 loss per share (vs CA$0.006 loss in 3Q 2023) Third quarter 2024 results: CA$0.006 loss per share (in line with 3Q 2023). Net loss: CA$1.18m (loss widened 41% from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 12% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings. Tillkännagivande • Aug 22
Bee Vectoring Technologies International Inc. Receives Mexican Approval on its Proprietary Biological for Commercial Use Bee Vectoring Technologies International Inc. announced the Company's proprietary Vectorite with Clonostachys Rosea CR-7 (CR-7) has been approved by Mexico's COFEPRIS (The Federal Commission for Protection from Sanitary Risks), the country's health authority responsible for registration of plant protection products, for use as a fungicide on commercial crops. The approval covers delivery of CR-7 using both bumble bees and honeybees on various high value crops, including the berry group of crops and indoor vegetables. Mexico's growers offer significant market potential for BVT's natural precision agriculture system: official statistics indicate that the country's production in 2019 included 41,600 acres of strawberries, 12,100 acres of blueberries and over 377,000 acres of tomatoes and peppers.(1) In the same year, US imports of fresh and processed fruits and vegetables from Mexico amounted to USD 15.6 billion. The country uses USD 1.3 billion worth of pesticides each year, but an increasing number of growers are turning to biologicals as an alternative that offers better quality, greater food safety and reduces the
need for chemicals. Mexico's COFEPRIS registration makes Vectorite with CR-7 available immediately for sale as a registered fungicide for use on the labelled crops. Reported Earnings • Jun 04
Second quarter 2024 earnings released: EPS: CA$0 (vs CA$0.004 loss in 2Q 2023) Second quarter 2024 results: EPS: CA$0 (improved from CA$0.004 loss in 2Q 2023). Revenue: CA$81.9k (down 77% from 2Q 2023). Net income: CA$20.9k (up CA$567.2k from 2Q 2023). Profit margin: 26% (up from net loss in 2Q 2023). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has fallen by 60% per year, which means it is significantly lagging earnings. Reported Earnings • Mar 03
First quarter 2024 earnings released: CA$0.011 loss per share (vs CA$0.011 loss in 1Q 2023) First quarter 2024 results: CA$0.011 loss per share (in line with 1Q 2023). Revenue: CA$17.0k (down 62% from 1Q 2023). Net loss: CA$1.65m (loss widened 12% from 1Q 2023). Over the last 3 years on average, earnings per share has increased by 15% per year but the company’s share price has fallen by 53% per year, which means it is significantly lagging earnings. Tillkännagivande • Mar 02
Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024 Bee Vectoring Technologies International Inc., Annual General Meeting, May 10, 2024. Location: Suite 1890 1075 West Georgia Street Vancouver British Columbia Canada Tillkännagivande • Feb 01
Bee Vectoring Technologies International Inc. Announces Paid Demonstration Trials in Mexico with Major Multi-National Grower Bee Vectoring Technologies International Inc. announced that a major multi-national grower is conducting demonstration trials in Mexico with BVT's proprietary Vectorite with CR-7 (Clonostachys rosea CR-7) biological fungicide and natural precision agriculture system. This multi-national grower is a key producer of blueberries, raspberries, blackberries and table grapes in Mexico. They have over 5,000 hectares worldwide for the production of berries, with additional operations in the US, Peru and Morocco. After the initial honeybee system trials in their Mexican operations, there is opportunity to expand BVT trials to the other countries. The BVT trials are staggered to the start of bloom time for each berry crop. They commenced last September with the start of blackberry and raspberry bloom periods, moved to blueberry in November, and lasts into early 2024. Trial data is being collected at each crop's harvest time and the grower is currently evaluating for yield performance and percentage of fruit spoilage with BVT and the grower standard applied versus the grower standard used alone. Geographic expansion is a key element in BVT's ongoing corporate expansion strategy. BVT's registration dossier was submitted to regulatory authorities in Mexico in April 2022, and BVT continues to build and expand strategic relationships with Mexican growers. This newest relationship with a multi-national grower with operations in Mexico is a vital step in the Company's continued development in the country. Reported Earnings • Jan 30
Full year 2023 earnings released: CA$0.034 loss per share (vs CA$0.041 loss in FY 2022) Full year 2023 results: CA$0.034 loss per share (improved from CA$0.041 loss in FY 2022). Revenue: CA$601.6k (up 21% from FY 2022). Net loss: CA$4.67m (loss narrowed 5.2% from FY 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 55% per year, which means it is significantly lagging earnings. Tillkännagivande • Jan 17
Bee Vectoring Technologies International Inc. Announces South African Trials with Major Multi-National Agribusiness Bee Vectoring Technologies International Inc. announced South African multi-national agricultural technology business Microbial Biological Fertilizers International (MBFi) has commenced trials of BVT products in South Africa. They will be evaluating BVT's patented bee vectoring dispenser for honeybees with proprietary Vectorite powder, initially testing with MBFi's own biological strain as a comparison with traditional spray applications. MBFi manufactures agricultural products for the South African farming industry, supplying fertilizer, biostimulants, biologicals and adjuvants. Trials are being conducted on grower crop fields including macadamias, avocados, apples, strawberries, blueberries and cherries, timed for the start of each crop's bloom period. MBFi will also extend the trials to include sunflowers and canola. In South Africa, macadamia, avocado, applies, strawberries, blueberries and cherry crops cover over 85,000 hectares of farmland, with sunflowers and canola adding another 520,000. Reported Earnings • Sep 03
Third quarter 2023 earnings released: CA$0.006 loss per share (vs CA$0.008 loss in 3Q 2022) Third quarter 2023 results: CA$0.006 loss per share (improved from CA$0.008 loss in 3Q 2022). Revenue: CA$203.2k (up 32% from 3Q 2022). Net loss: CA$836.2k (loss narrowed 9.7% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 25% per year but the company’s share price has fallen by 40% per year, which means it is significantly lagging earnings. Reported Earnings • Jun 02
Second quarter 2023 earnings released: CA$0.004 loss per share (vs CA$0.013 loss in 2Q 2022) Second quarter 2023 results: CA$0.004 loss per share (improved from CA$0.013 loss in 2Q 2022). Revenue: CA$360.6k (up 26% from 2Q 2022). Net loss: CA$546.3k (loss narrowed 64% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 23% per year but the company’s share price has fallen by 42% per year, which means it is significantly lagging earnings. Tillkännagivande • May 16
Bee Vectoring Technologies International Inc. announced that it has received CAD 0.27 million in funding On May 15, 2023, Bee Vectoring Technologies International Inc. closed the transaction. All securities issued pursuant to the transaction are subject to a statutory hold period which will expire on September 13, 2023 in accordance with applicable securities laws of Canada. Reported Earnings • Mar 03
First quarter 2023 earnings released: CA$0.011 loss per share (vs CA$0.009 loss in 1Q 2022) First quarter 2023 results: CA$0.011 loss per share (further deteriorated from CA$0.009 loss in 1Q 2022). Revenue: CA$44.5k (up 11% from 1Q 2022). Net loss: CA$1.48m (loss widened 37% from 1Q 2022). Over the last 3 years on average, earnings per share has increased by 22% per year but the company’s share price has fallen by 38% per year, which means it is significantly lagging earnings. Board Change • Dec 30
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Jim Molyneux was the last independent director to join the board, commencing their role in 2015. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Tillkännagivande • Nov 19
Bee Vectoring Technologies International Inc., Annual General Meeting, Jan 19, 2023 Bee Vectoring Technologies International Inc., Annual General Meeting, Jan 19, 2023. Reported Earnings • Jan 30
Full year 2021 earnings: Revenues and EPS in line with analyst expectations Full year 2021 results: CA$0.036 loss per share (up from CA$0.078 loss in FY 2020). Revenue: CA$399.1k (up 38% from FY 2020). Net loss: CA$4.12m (loss narrowed 39% from FY 2020). Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has fallen by 8% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Reported Earnings • Sep 01
Third quarter 2021 earnings released: CA$0.01 loss per share (vs CA$0.013 loss in 3Q 2020) Third quarter 2021 results: Net loss: CA$1.13m (loss narrowed 5.0% from 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 13% per year, which means it is well ahead of earnings. Board Change • Jul 31
High number of new directors Independent Director Mark Kohler was the last director to join the board, commencing their role in 2021. Recent Insider Transactions • Apr 20
Independent Director recently sold €49k worth of stock On the 13th of April, Jim Molyneux sold around 188k shares on-market at roughly €0.26 per share. This was the largest sale by an insider in the last 3 months. Insiders have been net sellers, collectively disposing of €222k more than they bought in the last 12 months. Is New 90 Day High Low • Feb 06
New 90-day high: €0.30 The company is up 66% from its price of €0.18 on 06 November 2020. The German market is up 15% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 26% over the same period. Reported Earnings • Feb 01
Full year 2020 earnings released: CA$0.078 loss per share (vs CA$0.037 loss in FY 2019) The company reported a solid full year result with improved revenues and control over costs, although losses increased. Full year 2020 results: Revenue: CA$288.9k (up 397% from FY 2019). Net loss: CA$6.72m (loss widened 132% from FY 2019). Over the last 3 years on average, earnings per share has fallen by 9% per year but the company’s share price has increased by 16% per year, which means it is well ahead of earnings. Is New 90 Day High Low • Jan 09
New 90-day high: €0.28 The company is up 49% from its price of €0.19 on 09 October 2020. The German market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 17% over the same period. Is New 90 Day High Low • Dec 23
New 90-day high: €0.24 The company is up 36% from its price of €0.18 on 24 September 2020. The German market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. 
